WEE1 and myotonic dystrophy type 1: Unraveling the mysteries of phosphorylation imbalances associated to DM1—namely the protein kinase and phosphatase levels and activity alterations—could represent a powerful strategy to implement new therapies and improve symptoms and overall quality of life of patients with DM1.